SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Klein C) ;srt2:(2015-2019);lar1:(ki)"

Sökning: WFRF:(Klein C) > (2015-2019) > Karolinska Institutet

  • Resultat 1-10 av 91
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  • Ruilope, LM, et al. (författare)
  • Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
  • 2019
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Gusev, A, et al. (författare)
  • Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
  • 2016
  • Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 7, s. 10979-
  • Tidskriftsartikel (refereegranskat)abstract
    • Although genome-wide association studies have identified over 100 risk loci that explain ∼33% of familial risk for prostate cancer (PrCa), their functional effects on risk remain largely unknown. Here we use genotype data from 59,089 men of European and African American ancestries combined with cell-type-specific epigenetic data to build a genomic atlas of single-nucleotide polymorphism (SNP) heritability in PrCa. We find significant differences in heritability between variants in prostate-relevant epigenetic marks defined in normal versus tumour tissue as well as between tissue and cell lines. The majority of SNP heritability lies in regions marked by H3k27 acetylation in prostate adenoc7arcinoma cell line (LNCaP) or by DNaseI hypersensitive sites in cancer cell lines. We find a high degree of similarity between European and African American ancestries suggesting a similar genetic architecture from common variation underlying PrCa risk. Our findings showcase the power of integrating functional annotation with genetic data to understand the genetic basis of PrCa.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 91
Typ av publikation
tidskriftsartikel (77)
konferensbidrag (12)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (74)
övrigt vetenskapligt/konstnärligt (17)
Författare/redaktör
Klein, C. (10)
Klein, M. (7)
Gibb, DM (6)
Giaquinto, C (5)
Kim, S. (5)
Cichon, S (5)
visa fler...
Heinz, A (5)
Marczynska, M (4)
Hottenga, JJ (4)
Zhang, Y. (4)
Agartz, I (4)
Andreassen, OA (4)
Melle, I (4)
Djurovic, S (4)
Brenner, H (4)
Boomsma, DI (4)
van Duijn, CM (4)
Penninx, BWJH (4)
Ikeda, M. (4)
MCDONALD, C (4)
Simmons, A. (4)
Ophoff, RA (4)
Bralten, J (4)
Mattheisen, M (4)
Milaneschi, Y (4)
Teumer, A (4)
Blangero, J (4)
Buckner, RL (4)
Cahn, W (4)
De Geus, EJC (4)
Donohoe, G (4)
Green, RC (4)
Gudnason, V (4)
Hartman, CA (4)
Jonsson, EG (4)
Kahn, RS (4)
Lovestone, S (4)
McIntosh, AM (4)
Montgomery, GW (4)
Morris, DW (4)
Muller-Myhsok, B (4)
Nauck, M (4)
Nothen, MM (4)
Rietschel, M (4)
Roffman, JL (4)
Smoller, JW (4)
Weinberger, DR (4)
Weiner, MW (4)
Martin, NG (4)
Launer, LJ (4)
visa färre...
Lärosäte
Umeå universitet (5)
Uppsala universitet (5)
Lunds universitet (5)
Linköpings universitet (3)
Stockholms universitet (2)
visa fler...
Örebro universitet (2)
Göteborgs universitet (1)
Linnéuniversitetet (1)
Högskolan Dalarna (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (91)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (26)
Naturvetenskap (5)
Samhällsvetenskap (2)
Teknik (1)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy